Leerink Bumps PT on Exelixis (EXEL) Up to $16 Following Latest Cabozantinib Data

Go back to Leerink Bumps PT on Exelixis (EXEL) Up to $16 Following Latest Cabozantinib Data
Exelixis, Inc. (NASDAQ: EXEL) Delayed: 52.81 +1.47 (2.86%)
Previous Close $51.34    52 Week High $17.00 
Open $51.88    52 Week Low $3.55 
Day High $53.09    P/E N/A 
Day Low $51.70    EPS $-1.33 
Volume 1,384,944